
The pharmaceutical and biotechnology sectors are currently navigating a period of intense transformation, characterized by multi-billion-dollar acquisitions and a radical shift toward specialized immunology. Dominic Jainy, an expert in the integration of artificial intelligence and blockchain within healthcare systems, provides a unique perspective on how these technological leaps are reshaping patient care. As we see a massive influx of capital










